SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group (Q84441542)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

SYT-SSX breakpoint peptide vaccines in patients with synovial sarcoma: a study from the Japanese Musculoskeletal Oncology Group (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

16

Hiroyuki Tsuchiya

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

10

Toshihiko Torigoe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

30

Noriyuki Sato

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

2

Tomohide Tsukahara

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

31

Takuro Wada

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

29

Toshihiko Yamashita

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

12

Akari Takahashi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

7

Makoto Emori

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1

Satoshi Kawaguchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

9

Mitsunori Kaya

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

3

Kazunori Ida

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

8

Satoshi Nagoya

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

5

Masaki Murase

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

6

Masanobu Kano

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

28

Hiroo Yabe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Shigeharu Kimura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Emiri Ueda

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Takeshi Ishii

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Shin-ichiro Tatezaki

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Junya Toguchida

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Toshihisa Osanai

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Takashi Sugita

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Hideshi Sugiura

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Makoto Ieguchi

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Koichiro Ihara

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Ken-ichiro Hamada

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Hiroshi Kakizaki

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Takeshi Morii

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Taketoshi Yasuda

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Taisuke Tanizawa

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Akira Ogose

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

7 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

1625-1630

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

Clinical evaluation of BCR-ABL peptide immunisation in chronic myeloid leukaemia: results of the EPIC study

5 February 2020

cites work

1 reference

12 December 2020

Inhibition of proliferation and induction of apoptosis in soft tissue sarcoma cells by interferon-alpha and retinoids

1 reference

12 December 2020

A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia

1 reference

12 December 2020

1 reference

12 December 2020

Immunotherapy of established (pre)malignant disease by synthetic long peptide vaccines

1 reference

12 December 2020

Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcoma

1 reference

12 December 2020

Immunotherapy with autologous dendritic cells and tumor-specific synthetic peptides for synovial sarcoma

1 reference

12 December 2020

Use of booster inoculations to sustain the clinical effect of an adjuvant breast cancer vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.

1 reference

12 December 2020

Oral anticoagulant-associated intracerebral hemorrhage

1 reference

12 December 2020

Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations

1 reference

12 December 2020

Synovial sarcoma: retrospective analysis of 250 patients treated at a single institution.

1 reference

12 December 2020

Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial

1 reference

12 December 2020

Current developments with peptide-based human tumor vaccines

1 reference

12 December 2020

Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma

1 reference

12 December 2020

Intracerebral hemorrhage in a patient receiving combination therapy of pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.

1 reference

12 December 2020

Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1

1 reference

12 December 2020

A new era in anticancer peptide vaccines

1 reference

12 December 2020

Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors

1 reference

12 December 2020

Uncommon side-effects of interferon

1 reference

12 December 2020

Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group.

1 reference

12 December 2020

IFN-alpha enhances peptide vaccine-induced CD8+ T cell numbers, effector function, and antitumor activity

1 reference

12 December 2020

The role of interferons in the treatment of osteosarcoma

1 reference

12 December 2020

Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02

1 reference

12 December 2020

Synthetic tumor-specific breakpoint peptide vaccine in patients with chronic myeloid leukemia and minimal residual disease: a phase 2 trial

1 reference

12 December 2020

Crisscross CTL induction by SYT-SSX junction peptide and its HLA-A*2402 anchor substitute

1 reference

12 December 2020

Intracerebral haemorrhage under interferon-beta therapy

1 reference

12 December 2020

Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma

1 reference

12 December 2020

Adjuvant immunization of HLA-A2-positive melanoma patients with a modified gp100 peptide induces peptide-specific CD8+ T-cell responses

1 reference

12 December 2020

HLA-A*0201-restricted CTL epitope of a novel osteosarcoma antigen, papillomavirus binding factor

1 reference

12 December 2020

Immunization of stage IV melanoma patients with Melan-A/MART-1 and gp100 peptides plus IFN-alpha results in the activation of specific CD8(+) T cells and monocyte/dendritic cell precursors.

1 reference

12 December 2020

Comparing children and adults with synovial sarcoma in the Surveillance, Epidemiology, and End Results program, 1983 to 2005: an analysis of 1268 patients

1 reference

12 December 2020

Immune thrombocytopenia and alpha-interferon therapy

1 reference

12 December 2020

Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) alone or administered in combination with interferon-alpha (IFN-alpha): a phase 2 trial

1 reference

12 December 2020

Synovial sarcoma in childhood and adolescence: a retrospective series of 77 patients registered by the Children's Cancer and Leukaemia Group between 1991 and 2006.

1 reference

12 December 2020

Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study

1 reference

12 December 2020

Complete molecular response in CML after p210 BCR-ABL1-derived peptide vaccination.

1 reference

12 December 2020

Peptide-based vaccines for cancer: realizing their potential

1 reference

12 December 2020

Diagnosis and management of synovial sarcoma

1 reference

12 December 2020

Immune-based therapies for sarcoma

1 reference

12 December 2020

Synovial sarcoma of children and adolescents: The prognostic role of axial sites

1 reference

12 December 2020

Determinants of intracranial hemorrhage incidence in patients on oral anticoagulation followed at the Lahey clinic.

1 reference

12 December 2020

Interferon-alpha 2b-induced thrombocytopenia is caused by inhibition of platelet production but not proliferation and endomitosis in human megakaryocytes

1 reference

12 December 2020

10.1111/J.1349-7006.2012.02370.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726592%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference